Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-012357
Filing Date
2017-12-15
Accepted
2017-12-15 12:05:50
Documents
48
Period of Report
2017-10-31

Document Format Files

Seq Description Document Type Size
1 10-Q csbr10-q10312017.htm 10-Q 722150
2 EXHIBIT 31.1 csbrq21031201710-qex311.htm EX-31.1 10385
3 EXHIBIT 31.2 csbrq21031201710-qex312.htm EX-31.2 10511
4 EXHIBIT 32.1 csbrq21031201710-qex321.htm EX-32.1 8131
  Complete submission text file 0001628280-17-012357.txt   3960834

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT csbr-20171031.xml EX-101.INS 895989
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20171031.xsd EX-101.SCH 30028
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT csbr-20171031_cal.xml EX-101.CAL 54784
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20171031_def.xml EX-101.DEF 116781
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20171031_lab.xml EX-101.LAB 400829
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20171031_pre.xml EX-101.PRE 220652
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-11504 | Film No.: 171258206
SIC: 2836 Biological Products, (No Diagnostic Substances)